CASE
REPORT
–
OPEN
ACCESS
InternationalJournalofSurgeryCaseReports16(2015)166–170
ContentslistsavailableatScienceDirect
International
Journal
of
Surgery
Case
Reports
jo u r n al ho me p a g e :w w w . c a s e r e p o r t s . c o m
Successful
adult-to-adult
living
donor
liver
transplantation
using
liver
allograft
after
the
resection
of
hemangioma:
A
suggestive
case
for
a
further
expansion
of
living
donor
pool
Yasuharu
Onishi
∗,
Hideya
Kamei,
Hisashi
Imai,
Nobuhiko
Kurata,
Tomohide
Hori,
Yasuhiro
Ogura
DepartmentofTransplantationSurgery,NagoyaUniversityHospital,Nagoya,Japan
a
r
t
i
c
l
e
i
n
f
o
Articlehistory:
Received13July2015 Receivedinrevisedform 17September2015 Accepted30September2015 Availableonline8October2015
Keywords: Hemangioma Livergraft Adult-to-adult Livingdonor Livertransplantation Donorpool
a
b
s
t
r
a
c
t
INTRODUCTION:Hepatichemangiomaisoneofthemostcommonbenignlivertumors.Therearefew publishedreportsregardinglivertransplantationusingliverallograftswithhemangioma.
PRESENTATIONOFCASE:A45-year-oldmanwasevaluatedasalivingdonorfor19-year-oldsonwith cirrhosisduetohepaticfibrosis.Preoperativeinvestigationsrevealed20and7mmhemangiomas,at seg-ment2(S2)and4(S4)respectively.ConsideringtheanatomicalrelationofS2hemangiomaandGlisson 2,livergraftwasdesignedasleftlobeexcludedS2hemangiomabypartialresection.Estimatedgraft recipientweightratio(GRWR)evenafterpartialresectionofhemangiomawasreasonable.Duringthe donoroperation,apartialhepaticresectionofS2hemangiomawasperformed.Intraoperative patho-logicfindingsrevealedacavernoushemangioma,andthen,thelefthepaticgraftwiththecaudatelobe washarvested.ActualGRWRwas0.90%.Donor’spostoperativecoursewasuneventful.Recipient’s post-operativecoursewasalmostuneventful.Postoperativecomputedtomographyoftherecipientshowed thegraftregenerationwithoutincreaseorrecurrenceofhemangioma.
DISCUSSION:Organshortageisamajorconcerninthefieldoflivertransplantation.Anoveldonorsource withafurtheroptionisextremelycrucialforaguaranteeoflivertransplantation.Weexperiencedthe firstcaseofadult-to-adultlivingdonorlivertransplantationusingliverallograftaftertheresectionof hemangioma.
CONCLUSION:Weadvocatethattheuseofliverallograftwithhemangiomasinadult-to-adultLDLT set-tingscanberemarkablestrategytoreducetheproblemoforganshortagewithoutanyunfavorable consequencesinbothlivingdonorandrecipient.
©2015TheAuthors.PublishedbyElsevierLtd.onbehalfofSurgicalAssociatesLtd.Thisisanopen accessarticleundertheCCBY-NC-NDlicense(http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Becausethe usageof extended criteria for donation of liver
transplantationhasbeenneededduetodonororganscarcityfor
transplantation [1],liver graftsfrommarginal donorsincluding
liverwithbenigntumorshavebeenacceptedastreatmentoptions.
Hepatichemangiomaisoneofthemostcommonbenigntumorsof
theliver,asdescribedupto7%inautopsyfindings[2].
Thehemangiomausually remainsasymptomatic[3] andhas
abenigncourse[4–6],althoughsymptomatichemangiomasmay
rarelyrequireeither interventional orsurgicaltreatment[7–9].
Abbreviations: LDLT,livingdonorlivertransplantation;GRWR,graftrecipient
weightratio;POD,post-operativeday;GV/SLV,graftlivervolumetostandardliver volume.
∗Correspondingauthorat:65Tsurumai-cho,Showa-ku,Nagoya466-8550,Japan. Fax:+81527442293.
E-mailaddress:onishiy@med.nagoya-u.ac.jp(Y.Onishi).
Therearefew publishedreports regarding livertransplantation
using liver allografts with hemangiomas [10–16]. In not only
deceased donorlivertransplantation butalsoliving donorliver
transplantation (LDLT), liver allograftswith hemangiomashave
beenutilizedfortransplantation.However,inLDLTsetting,there
areonlytwopublishedreportsaboutliverallograftswith
heman-gioma,andtheywerebothlivertransplantsforpediatricrecipients
[12,15].Untilnow,therehasbeennoreportinadult-to-adultLDLT
withlivergraftswithhemangioma.
We presentherethe firstreportof successfuladult-to-adult
LDLTusingliverallograftwithhemangioma.
2. Presentationofcase
A 19-year-old male was admitted with liver failure due to
congenitalhepatic fibrosis.Aprior diagnosisofcongenital
hep-aticfibrosis had been establishedby gastroenterologists before
13years. Hisliverfunctiondeterioratedprogressively,withthe
http://dx.doi.org/10.1016/j.ijscr.2015.09.043
2210-2612/©2015TheAuthors.PublishedbyElsevierLtd.onbehalfofSurgicalAssociatesLtd.ThisisanopenaccessarticleundertheCCBY-NC-NDlicense(http://
Fig.1. Preoperativecontrast-enhancedabdominalcomputedtomography(A,B)andmagneticresonanceimaging(C,D)ofthedonorliverwithcavernoushemangiomas.S2 hemangiomawasindicatedbyarrowheads,andS4hemangiomawasindicatedbyarrows.
following laboratory findings: serum total bilirubin 25.2mg/dl, prothrombintime-internationalnormalizedratio1.78,aspartate aminotransaminase119IU/l,andalanineaminotransferase71IU/l. Noruptureofesophagealandgastricvariceswasseen.However,he hadsomecriticalepisodesofgrade2hepaticencephalopathy,and intensivecaresincludingplasmaexchangewasseriouslyrequired. ThepreoperativeliverprofilewasevaluatedasChild-Pugh classi-ficationofgradeC(11points)andanMELD(ModelforEndStage LiverDisease)scoreof34points.
A45-year-oldmalewasevaluatedasalivingdonorforhisson. Theliverfunctiontestsofthedonorweretotallywithinthenormal rangewithnoevidenceofanycoagulopathy.Donorpreoperative computedtomographyandmagneticresonanceimagingrevealed 20mmand7mmhemangiomas,atsegment2(S2)and4 respec-tively(Fig.1).Estimatedleftlobevolumewiththecaudatewas
503ml.ConsideringtheanatomicalrelationshipofS2hemangioma
andGlisson2,livergraftwasdesignedastheleftlobegraftwith
caudatelobeexcludedS2hemangiomabypartialresection(Fig.2).
Estimatedgraftvolumeafterhemangiomapartialresectionwas
482ml,whichaccountedfor0.83%ofgraftrecipientweightratio
(GRWR).
Thus,therecipientstatuswasanend-stageliverdisease(i.e.,
advancedlivercirrhosis),andthisdonorwasonlyacandidatefor
thisrecipient.Afteranapprovalofinstitutionalethicalcommittee,
wescheduledLDLTforthiscase.
A LDLT donor and recipient procedure was performed as
describedelsewhere[17,18].Atthebeginningoflivingdonor
oper-ation,invivopartialhepaticresectionoftheS2hemangiomawas
performed without thePringle maneuver. Intraoperative
ultra-sonographywasusedtoidentifythelocationofS2hemangiomaand
Glisson2toavoidtheinjurytoGlisson2structures(Fig.3A).The
resectedspecimenfromthedonorliverwasconfirmedtobea
cav-ernoushemangiomabyanintraoperativepathologicexamination,
andthen,thelefthepaticgraftwithcaudatelobewasharvested.
Thedonoroperationtimewas521min,andthebleedingvolumeof
thedonoroperationwas1250ml,butmostofthebleedingoccurred
Fig.2. The3D-imagesimulation.HemangiomawasshowninH,withpartial resec-tionmargin.
aftertheresectionofthehemangioma.Theactuallivergraftweight
was504g,andresultinginanactualGRWRof0.90%.
Therecipientoperationwasperformedwithstandard
proce-dures.Atthetimeofreperfusion,nobleedingwasobservedfrom
theresectionsiteofS2hemangioma(Fig.3B).Splenectomywas
added in this case, because of the existence of splenic artery
aneurysm.Recipientoperationtimewas632min,andbloodloss
was5320ml.
Thedonor’spostoperativecoursewasalmostuneventful,andhe
wasdischargedfromthehospitalonthepost-operativeday(POD)
12.TherecipientwasdischargedfromthehospitalonPOD31
with-outsubsequentlivernecrosisorbileleakage fromtheresection
siteofS2hemangioma.However,onPOD39,therecipientwas
re-admittedtothehospitalbecauseoftheintra-abdominalbleeding,
andurgentoperationwasperformedforhemostasis.Thecauseof
bleedingwasgastricvarixruptureclosetosplenectomysite,and
heman-CASE
REPORT
–
OPEN
ACCESS
168 Y.Onishietal./InternationalJournalofSurgeryCaseReports16(2015)166–170Fig.3.(A)Donoroperation.Ultrasoundsonogramwasusedtoconfirmthelocation ofS2hemangiomaandGlisson2.Locationofhemangiomawasindicatedbywhite arrows.(B)Finalviewofrecipientoperation.NotenoGlisson2injuredafterpartial resectionofhemangioma.
gioma.Hewasdischargedfromhospital8weeksafterthesecond operationwithgoodgeneralconditionandlivergraftfunction.He iscurrentlydoingwell2yearsaftertheLDLT.Also,therecipient’sCT scansonthepost-operative132daysand19monthsshowedthat thegoodregenerationofthelivergraftwithoutanyrecurrenceor growthofhemangioma(Fig.4).
3. Discussion
Althoughlivertransplantationhasbeenwidelyperformedfor
end-stageliverfailure,organshortageisthegreatestproblem
fac-ingthefieldoforgantransplantationtoday.Therefore,theusage
ofextendedcriteriadonorsfororgantransplantationhasbecomea
necessityduetodonororganscarcityfortransplantation[1].
Actu-ally,theuseofmarginalorexpandedpooldonorswasshownto
haveoutcomesimilartoideallivergraft[19].Inrenal
transplan-tation,Khurram etal. reportedthatuseof kidneys aftertumor
resectionseemsafeasiblesourcetoincreasethedonorpool[20].
Thus,itisextremelyimportanttotrytouseanoveldonorsourceasa
furtheroptiontoincreasethenumberofpatientswhomightbeable
toreceivealivertransplantationaswellaskidneytransplantation.
Hepatic hemangioma is one of the most common hepatic
tumors.TheMayoClinicteamsuggestedthatmostliver
heman-giomacouldbeobservedsafely[4],andFargesetal.confirmedthe
statement[5].However,therearefewpublishedreportsregarding
livertransplantationusingliverallograftswithhemangiomasofar. Table
1 Review of the documented reports of liver allografts with hemangioma. Case no. Year Author Reference Deceased/living donor Donor age Recipient age Hemangioma Size Location Resection Size after transplantation 1 1995 Mor et al. [10] Deceased 54 30 10 × 10 × 8 cm Posterior segment Done at backtable Unknown 2 2005 Onaca et al. [11] Deceased 65 59 9 cm, 3 cm Right lobe, left lobe Done at backtable No recurrence 3 2005 Pacheco-Moreira et al. [12] Living 32 4 4.2 cm Lateral segment No Unknown 4 2006 Aucejo et al. [13] Deceased 65 53 10 × 8 × 9 Right lobe No Reduction 5 2007 Nikeghbalian et al. [14] Deceased 36 37 20% of whole liver Right lobe No Reduction 6 2011 Sanada et al. [15] Living 27 2 2 cm Lateral segment Done in operation No recurrence 7 2013 Sun et al. [16] Living (otherwise discarded) 41 27 7.8 cm Left lobe No No change Our case 2015 Onishi et al. Living 45 19 2 cm, 0.7 cm S2, S4 Done in operation, no No recurrence, no change
Fig.4.Post-operativeCTfindingsintherecipient.TheCTfindingsat132days(A) andat19months(B)wereshown.
AsshowninTable1,sevencasesofdonorliverswith
heman-giomas have been reported previously [10–16].There are only
tworeportsof leftlateralsegmentfromalivingdonor
contain-ing hemangioma transplanted to pediatric patients but not to
adultpatients[12,15]. WhileSunet al.indicated adult-to-adult
livertransplantationofanotherwisediscardedpartialliver
allo-graftwithacavernoushemangioma[16],therehasbeennoreport
aboutadult-to-adult LDLTusingliverallograftwitha cavernous
hemangioma.Toourknowledge,thisisthefirstcase
demonstrat-ingadult-to-adultlivertransplantationusinglefthepaticlobegraft
withcaudatelobeaftertheresectionofhemangiomafromaliving
donor.
Sanadaetal.haveproposeda strategyfortheusageofliver
allograftwithhemangiomasinpediatricLDLTsettings[15].They
proposedthattheresectionofhemangiomasdependsonthetumor
location,theestimatedgraftlivervolumetostandard liver
vol-ume(GV/SLV)ratioafterthetumorresection,andthetumorsize.
HemangiomasataperipherallocationandtheestimatedGV/SLV
ratioof40%andmoreafterthetumorresectionareconsideredto
beanindicationofsurgicalresection.Similartotheirproposal,we
resectedthe20mmhemangiomaofS2,becausethehemangioma
wasrelativelylargeratperipheralsite,andtheestimatedGRWR,
whichwe useinsteadofGV/SLVratio,aftertheresectionofS2
hemangiomawas0.83%.Ontheotherhand,smaller7mm
heman-giomaatS4wasnotresectedbecausethelocationwasrelatively
centralandthesizewassmaller.Thesizeandfeatureofthe
heman-giomainthetransplantedlivershouldbestrictlyfollowed,because
detailedlong-termedanalysisofliverallograftwithhemangioma
hasnotbeenperformedandapossibilityofsymptomaticchanges
mayremain.
Technicallyspeaking,inordertoresectthehemangioma,there
aretwosurgicalprocedures,backtableresection[10,11]orinvivo
resectioninthedonorsurgery[15].Wechoseinvivo resection
duringthedonoroperation,becausewebelievethatinvivo
pro-cedurecontainstheeasieranatomicalresectionofthetumorand
theshortercoldischemictimethanbacktableresection.
4. Conclusions
Our case is the first reportof adult-to-adult transplantation
usingalivingdonorlivergraftaftertheresectionofhemangioma.
Based onourexperience,donor liverwithhemangiomacan be
safelyusedevenfor adult-to-adultLDLT,whilethefollow-upis
neededincaseofthehemangiomaremainedinthetransplanted
liver.Weadvocatethatliverallograftswithhemangiomasshould
notbeconsideredasacontraindicationforadult-to-adultLDLT,and
canbeacceptedasapotentialliverallograft.
Conflictofinterest
Nofinancialconflictsofinterest.
Funding
Allauthorsdidnotreceiveanyfundingforthisreport.
Ethicalapproval
Thiscasereportiswrittenbasedoninstitutionalethical
com-mittee.
Consent
Writteninformedconsentwasobtainedfromthepatientfor
publicationofthisCasereportandanyaccompanyingimages.A
copyofthewrittenconsentisavailableforreviewbythe
Editor-in-Chiefofthisjournal.
Authorcontributions
YasuharuOnishicontributedreportsretrievalanddraftingof
this manuscript. Yasuharu Onishi, Hideya Kamei and Yasuhiro
Oguracontributedsurgicalproceduresofthiscasereport.Hisashi
ImaiandNobuhikoKuratacontributesdacquisitionofclinicaldata.
Tomohide Hori contributed critical revision of this manuscript.
Yasuhiro Ogura supervised this report. All authors read and
approvedthefinalmanuscript.
Guarantor
The guarantorof this manuscript is Yasuharu Onishi,
corre-spondingauthor.
References
[1]E.Mor,G.B.Klintmalm,T.A.Gonwa,H.Solomon,M.J.Holman,J.F.Gibbs,I.
Watemberg,R.M.Goldstein,B.S.Husberg,Theuseofmarginaldonorsforliver
transplantation.Aretrospectivestudyof365liverdonors,Transplantation53
(1992)383–386.
[2]C.K.Charny,W.R.Jarnagin,L.H.Schwartz,H.S.Frommeyer,R.P.DeMatteo,Y.
Fong,L.H.Blumgart,Managementof155patientswithbenignlivertumours,
Br.J.Surg.88(2001)808–813.
[3]P.A.Vagefi,I.Klein,B.Gelb,B.Hameed,S.L.Moff,J.P.Simko,O.K.Fix,H.Eilers,
J.R.Feiner,N.L.Ascher,C.E.Freise,N.M.Bass,Emergentorthotopicliver
transplantationforhemorrhagefromagiantcavernoushepatichemangioma:
casereportandreview,J.Gastrointest.Surg.15(2011)209–214.
[4]V.F.Trastek,J.A.vanHeerden,P.F.Sheedy2nd,M.A.Adson,Cavernous
CASE
REPORT
–
OPEN
ACCESS
170 Y.Onishietal./InternationalJournalofSurgeryCaseReports16(2015)166–170[5]O.Farges,S.Daradkeh,H.Bismuth,Cavernoushemangiomasoftheliver:are
thereanyindicationsforresection,WorldJ.Surg.19(1995)19–24.
[6]S.S.Yoon,C.K.Charny,Y.Fong,W.R.Jarnagin,L.H.Schwartz,L.H.Blumgart,
R.P.DeMatteo,Diagnosis,management,andoutcomesof115patientswith
hepatichemangioma,J.Am.Coll.Surg.197(2003)392–402.
[7]M.Birth,J.Ortlepp,S.Bontikous,M.Amthor,H.F.Weiser,H.P.Bruch,
Intermittentactivity-inducedhemobiliacausedbyliverhemangioma,Dig.
Surg.17(2000)292–296.
[8]N.Corigliano,P.Mercantini,P.M.Amodio,G.Balducci,S.Caterino,G.
Ramacciato,V.Ziparo,Hemoperitoneumfromaspontaneousruptureofa
gianthemangiomaoftheliver:reportofacase,Surg.Today33(2003)
459–463.
[9]Y.Kumashiro,M.Kasahara,K.Nomoto,M.Kawai,K.Sasaki,T.Kiuchi,K.
Tanaka,Livingdonorlivertransplantationforgianthepatichemangiomawith
Kasabach–Merrittsyndromewithaposteriorsegmentgraft,LiverTranspl.8
(2002)721–724.
[10]E.Mor,P.Boccagni,S.N.Thung,P.A.Sheiner,S.Emre,S.R.Guy,M.E.Schwartz,
C.M.Miller,Backtableresectionofagiantcavernoushemangiomainadonor
liver,Transplantation60(1995)616–617.
[11]N.Onaca,S.Mizrahi,N.BarNathan,I.Burstein,E.Mor,Livertransplantation
afterbacktableresectionofgianthemangioma,LiverTranspl.11(2005)
851–852.
[12]L.F.Pacheco-Moreira,M.Enne,E.Balbi,G.Santalucia,J.M.Martinho,
Hemangiomaattheliversectionplane.Isitacontraindicationforliving
donorlivertransplantation?Surgery138(2005)113.
[13]F.N.Aucejo,W.A.Ortiz,D.Kelly,D.C.Winans,D.Vogt,B.Eghtesad,J.J.Fung,
C.M.Miller,Expandingthedonorpool:safetransplantationofacadaveric
liverallograftwitha10cmcavernoushemangioma—acasereport,Liver
Transpl.12(2006)687–689.
[14]S.Nikeghbalian,K.Kazemi,H.Salahi,A.Bahador,H.R.Davari,H.Jalaeian,A.R.
Rasekhi,S.M.Nejatollahi,S.Gholami,S.A.Malek-Hosseini,Transplantationof
acadavericliverallograftwithrightlobecavernoushemangioma,without
back-tableresection:acasereport,Transplant.Proc.39(2007)1691–1692.
[15]Y.Sanada,K.Mizuta,T.Urahashi,M.Umehara,T.Wakiya,N.Okada,S.Egami,
S.Hishikawa,T.Fujiwara,Y.Sakuma,M.Hyodo,Y.Yasuda,Pediatricliving
donorlivertransplantationusingliverallograftwithhemangioma,Ann.
Transplant.16(2011)66–69.
[16]B.Sun,X.Mu,X.Wang,Successfuladult-to-adultlivertransplantationofan
otherwisediscardedpartialliverallograftwithacavernoushemangioma:
newstrategyforexpandingliverdonorpool,Transpl.Int.26(2013)e79–e80.
[17]K.Tanaka,S.Uemoto,Y.Tokunaga,S.Fujita,K.Sano,T.Nishizawa,H.Sawada,
I.Shirahase,H.J.Kim,Y.Yamaoka,Surgicaltechniquesandinnovationsin
livingrelatedlivertransplantation,Ann.Surg.217(1993)82–91.
[18]Y.Soejima,M.Shimada,T.Suehiro,K.Kishikawa,R.Minagawa,S.Hiroshige,
M.Ninomiya,S.Shiotani,N.Harada,K.Sugimachi,Feasibilityofduct-to-duct
biliaryreconstructioninleft-lobeadult-living-donorlivertransplantation,
Transplantation75(2003)557–559.
[19]N.Goldaracena,E.Quinonez,P.Mendez,M.Anders,F.OrozcoGanem,R.
Mastai,L.McCormack,Extremelymarginallivergraftsfromdeceaseddonors
haveoutcomesimilartoidealgrafts,Transplant.Proc.44(2012)2219–2222.
[20]M.A.Khurram,A.O.Sanni,D.Rix,D.Talbot,Renaltransplantationwith
kidneysaffectedbytumours,Int.J.Nephrol.529080(2011).
OpenAccess
ThisarticleispublishedOpenAccessatsciencedirect.com.ItisdistributedundertheIJSCRSupplementaltermsandconditions,which
permitsunrestrictednoncommercialuse,distribution,andreproductioninanymedium,providedtheoriginalauthorsandsourceare